Series date: 
10/01/2019 - 7:00am EDT to 12/31/2023 - 8:30am EST


A multidisciplinary team approach to care is fostered through peer-to-peer discussion and collaboration. The team discussion pertaining to diagnosis and treatment includes radiological and pathological findings and immunohistochemical testing to bridge gaps across the continuum of care and enhance the overall quality of patient-centered oncology care.


Medical Oncologists, Radiation Oncologists, Breast Cancer Surgeons, General Surgeons, Pathologists, Radiologists, Gynecologists, Pharmacists, Nurses, Social Workers, Radiologic Technologists, Patient Care Facilitators and all personnel involved in the care of the breast cancer patient.

•    Improve clinical decision making, clinical outcomes, and patient experience via a multidisciplinary team approach. Group discussion include prospective patient care management, national treatment guidelines, staging, and options and eligibility for genetic testing, clinical research studies, and supportive care services.
•    Develop a comprehensive treatment plan for dermatology oncology patients leveraging imaging and pathology testing results and meet Commission on Cancer accreditation standards compliance. 



Jane E. Mendez, M.D. 
Chief, Breast Surgery  
Miami Cancer Institute 

Jane Mendez, M.D., conference director of this educational activity, has no relevant financial relationships with ineligible companies* to disclose, and has indicated that the presentations or discussions will not include off-label or unapproved product usage.

Cris Alegria, Dora Escobeda, Stephanie Moreno and others involved in the planning, development, and editing/review of the content have no relevant financial relationships with ineligible companies to disclose.*

*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Disclosure Policy and Disclaimer


Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians. 

Baptist Health South Florida designates these live activities for a maximum of 1.5 AMA PRA Category 1 Credit™. each. Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

These activities have been approved for 1.5 credit hours, CE Broker Course #20-453018, by the Florida Boards of Medicine and Osteopathic Medicine.

These activities have also been approved for 1.5 credits for Nursing, Pharmacy, Clinical Social Work, Marriage & Family Therapy & Mental Health Counseling. Baptist Health South Florida CE Broker Provider #50-182.


American Board of Surgery - Maintenance of Certification (MOC) - Accredited CME - Complex  General Surgical Oncology

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

     Successful completion of this course is submitted to specialty boards through the ACCME's PARS system. 

Series location: 
Baptist Hospital
8900 N. Kendall Dr
Miami, FL 33176
United States


Session Date
Breast Cancer Tumor Board 11/13/2020 - 7:00am to 8:00am EST
Breast Cancer Tumor Board 11/20/2020 - 7:00am to 8:00am EST
Breast Cancer Tumor Board 12/04/2020 - 7:00am to 8:00am EST
Breast Cancer Tumor Board 12/11/2020 - 7:00am to 8:00am EST
Breast Cancer Tumor Board 12/18/2020 - 7:00am to 8:00am EST
Breast Cancer Tumor Board 01/08/2021 - 7:00am to 8:00am EST
Breast Cancer Tumor Board 01/15/2021 - 7:00am to 8:00am EST
Breast Cancer Tumor Board 01/22/2021 - 7:00am to 8:00am EST
Breast Cancer Tumor Board 01/29/2021 - 7:00am to 8:00am EST
Breast Cancer Tumor Board 02/05/2021 - 7:00am to 8:00am EST